CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-26 | BESHAR LUKE M Director | Sale | −1,721 | $65.00 | $112K | 0 |
| 2018-11-26 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −1,721 | 8,175 | ||
| 2018-11-26 | Mills Kenneth T. President and CEO | Sale | −11,380 | $63.81 | $726K | 259,620 |
| 2018-11-26 | Mills Kenneth T. President and CEO | Sale | −8,620 | $64.64 | $557K | 251,000 |
| 2018-11-21 | Mills Kenneth T. President and CEO | Sale | −1,300 | $60.09 | $78K | 284,700 |
| 2018-11-21 | Mills Kenneth T. President and CEO | Sale | −6,802 | $61.22 | $416K | 277,898 |
| 2018-11-21 | Mills Kenneth T. President and CEO | Sale | −6,898 | $61.92 | $427K | 271,000 |
| 2018-11-20 | BESHAR LUKE M Director | Exercise or conversion | +4,688 | $22.00 | $103K | 4,688 |
| 2018-11-20 | BESHAR LUKE M Director | Exercise or conversion | +2,988 | $12.74 | $38K | 7,676 |
| 2018-11-20 | BESHAR LUKE M Director | Exercise or conversion | +13,500 | $3.76 | $51K | 21,176 |
| 2018-11-20 | BESHAR LUKE M Director | Sale | −21,176 | $60.38 | $1.3M | 0 |
| 2018-11-20 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −4,688 | 4,687 | ||
| 2018-11-20 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −2,988 | 6,250 | ||
| 2018-11-20 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −13,500 | 66,500 | ||
| 2018-11-19 | BESHAR LUKE M Director | Exercise or conversion | +2,604 | $49.45 | $129K | 2,604 |
| 2018-11-19 | BESHAR LUKE M Director | Exercise or conversion | +6,250 | $18.85 | $118K | 8,854 |
| 2018-11-19 | BESHAR LUKE M Director | Exercise or conversion | +3,262 | $12.74 | $42K | 12,116 |
| 2018-11-19 | BESHAR LUKE M Director | Sale | −10,916 | $60.26 | $658K | 1,200 |
| 2018-11-19 | BESHAR LUKE M Director | Sale | −600 | $62.81 | $38K | 600 |
| 2018-11-19 | BESHAR LUKE M Director | Sale | −600 | $63.53 | $38K | 0 |
Page 33 of 43 · 852 trades